Literature DB >> 1350263

Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus.

C Larsson1, G Weber, E Kvanta, K Lewis, M Janson, C Jones, T Glaser, G Evans, M Nordenskjöld.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is characterized by neoplasia of the parathyroids, the pancreas, and the pituitary. Tumorigenesis involves unmasking of a recessive mutation at the MEN1 locus, which has been mapped to the centromeric part of chromosomal region 11q. In order to localize the MEN1 gene further and to make its isolation possible, a number of new markers were isolated. Two radiation-reduced somatic cell hybrids were identified that only contained markers close to and flanking the MEN1 region. DNA from these hybrids was used for the construction of a cosmid library, and clones containing human inserts were isolated. In addition, cosmid clones were isolated for locus expansion of 7 other markers that were mapped to the 11q12-13.2 region. The 33 newly isolated clones together with 25 previously published markers from this region were analyzed in a panel of radiation-reduced somatic cell hybrids. From the hybridization pattern, the region was divided into 11 parts. New restriction fragment length polymorphisms were identified in 7 of the newly isolated cosmid clones and in one plasmid. These were then used to sublocalize meiotic cross-overs more precisely in two MEN1 families, thus refining the mapping of the disease gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350263     DOI: 10.1007/bf00217121

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

Review 1.  Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms.

Authors:  K K Kidd; A M Bowcock; J Schmidtke; R K Track; F Ricciuti; G Hutchings; A Bale; P Pearson; H F Willard; J Gelernter
Journal:  Cytogenet Cell Genet       Date:  1989

2.  High efficiency vectors for cosmid microcloning and genomic analysis.

Authors:  G A Evans; K Lewis; B E Rothenberg
Journal:  Gene       Date:  1989-06-30       Impact factor: 3.688

3.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

4.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

Authors:  E Friedman; K Sakaguchi; A E Bale; A Falchetti; E Streeten; M B Zimering; L S Weinstein; W O McBride; Y Nakamura; M L Brandi
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

5.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

Authors:  R V Thakker; P Bouloux; C Wooding; K Chotai; P M Broad; N K Spurr; G M Besser; J L O'Riordan
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

6.  Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.

Authors:  C Larsson; J Shepherd; Y Nakamura; C Blomberg; G Weber; B Werelius; N Hayward; B Teh; T Tokino; B Seizinger
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.

Authors:  Y Tsujimoto; E Jaffe; J Cossman; J Gorham; P C Nowell; C M Croce
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

8.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

Authors:  M Taira; T Yoshida; K Miyagawa; H Sakamoto; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

Authors:  C Byström; C Larsson; C Blomberg; K Sandelin; U Falkmer; B Skogseid; K Oberg; S Werner; M Nordenskjöld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Localization of the gene encoding a type I protein phosphatase catalytic subunit to human chromosome band 11q13.

Authors:  H M Barker; T A Jones; E F da Cruz e Silva; N K Spurr; D Sheer; P T Cohen
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

View more
  11 in total

1.  Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.

Authors:  S Grimmond; G Weber; C Larsson; M Walters; B Teh; J Shepherd; M Nordenskjold; N Hayward
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

2.  Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization.

Authors:  A Szeles; S Bajalica-Lagercrantz; A Lindblom; T Lushnikova; V I Kashuba; S Imreh; M Nordenskjöld; G Klein; E R Zabarovsky
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

Review 3.  Irradiation and fusion gene transfer.

Authors:  M A Walter; P N Goodfellow
Journal:  Mol Biotechnol       Date:  1995-04       Impact factor: 2.695

4.  Localization of the Catf1 transcription factor gene to mouse chromosome 19.

Authors:  G Sebastiani; D Durocher; P Gros; M Nemer; D Malo
Journal:  Mamm Genome       Date:  1995-02       Impact factor: 2.957

5.  Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; N K Hayward; M K Walters; J J Shepherd; S Wilkinson; M Nordenskjold; C Larsson
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

6.  Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome.

Authors:  A Morelli; A Falchetti; R Castello; L Furlani; P Tomassetti; F Tonelli; A Frilling; M Serio; M L Brandi
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

7.  Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.

Authors:  A Lindblom; K Sandelin; L Iselius; J Dumanski; I White; M Nordenskjöld; C Larsson
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

8.  Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant.

Authors:  C M Smith; S A Wells; D S Gerhard
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

Review 9.  Genetics of cancer predisposition and progression.

Authors:  K Schwechheimer; W K Cavenee
Journal:  Clin Investig       Date:  1993-06

10.  Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.

Authors:  E M Petty; J S Green; S J Marx; R T Taggart; N Farid; A E Bale
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.